SHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS, MOGAM INST BIOMEDICAL RES and PRECIGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | New Zealand | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Animal care | |
#6 | Analysing materials | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Yao Yao | 11 |
#2 | Li Peng | 10 |
#3 | Lin Simiao | 9 |
#4 | Zhao Ruocong | 4 |
#5 | Lai Yunxin | 4 |
#6 | Tang Chaoyang | 3 |
#7 | Jiang Zhiwu | 2 |
#8 | The Inventor Has Waived The Right To Be Cited | 2 |
#9 | Cui Yuanbin | 2 |
#10 | Li Shanglin | 2 |
Publication | Filing date | Title |
---|---|---|
CN111995689A | Genetically modified immune cell and preparation method and application thereof | |
CN111944062A | Chimeric antigen receptor for recognizing Fc fragment and application thereof | |
CN111748043A | Chimeric antigen receptor and application thereof | |
CN111635912A | Gene combination for inducing liver cells into liver cancer cells and application thereof | |
CN110684739A | Chimeric antigen receptor T cell and application thereof | |
CN110713983A | Immune cell for expressing hyaluronidase and application thereof | |
CN110055224A | A kind of immunocyte of gene modification and its preparation method and application | |
CN107573419A | A kind of nucleic acid molecules for strengthening T cell antitumor activity | |
CN107624119A | A kind of molecule, the cell for expressing it and its production and use | |
NZ722076A | Chimeric antigen receptor containing a toll-like receptor intracellular domain |